Macitentan
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 522 publications
Pulmonary vasodilator therapy in COPD-associated pulmonary hypertension: A real-world case series of 14 patients confirmed by right heart catheterization.
Journal: Respiratory medicine case reports
Published: May 12, 2026
Regression of T-LGL leukemia in a patient treated with sildenafil for pulmonary hypertension.
Journal: Leukemia research
Published: April 08, 2026
Unrepaired Truncus Arteriosus Type 1 With Eisenmenger Syndrome and Recurrent Embolic Strokes: An Adult Case Report.
Journal: The American journal of case reports
Published: March 11, 2026
Corrigendum to "Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO)" [Vascular Pharmacology 162 (2026) 107585].
Journal: Vascular pharmacology
Published: February 26, 2026
Delayed-onset portopulmonary hypertension following liver transplantation with near hemodynamic normalization on triple therapy.
Journal: Respiratory medicine case reports
Published: February 22, 2026
Eisenmenger Syndrome Complicated by Hemorrhagic Hereditary Telangiectasia: Unique Intersection of Hemorrhage, Cyanosis, and Thrombosis.
Journal: JACC. Case reports
Published: February 06, 2026
Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis.
Journal: JHLT open
Published: January 22, 2026
Effect of Once-Daily Macitentan 75 mg on the Pharmacokinetics of Sildenafil, Riociguat, or Rosuvastatin in Healthy Male Participants.
Journal: Journal of clinical pharmacology
Published: January 14, 2026
A Real-World Disproportionality Analysis of Drug-Induced Heart Failure: Integrating FAERS Database and AHA Statement.
Journal: Cardiovascular toxicology
Published: December 28, 2025
Last Updated: 06/30/2026